Updates

It’s Time To Go To Work To Lower Prescription Drug Prices

Nov 12, 2018

Now that the midterms are over, it is now time for candidates to do what they Read More

CSRxP Statement on 2018 Midterm Election Results

Nov 7, 2018

Out-of-control drug prices was a prominent issue on the campaign trail. With Read More

On Message: Big Pharma Executives Double Down On Monopolistic Business Strategy

Nov 6, 2018

Executives of three major drug manufacturers – Pfizer, Merck and AbbVie – Read More

Voters want solutions to out-of-control drug prices

Nov 2, 2018

The American economy may be booming and paychecks may be growing Read More

ICYMI: CSRxP Corrects The Record On Price Transparency

Oct 31, 2018

The Trump Administration took another step earlier this month to help lower Read More

CSRxP Statement On The Trump Administration’s Proposal To Change Medicare Drug Prices

Oct 25, 2018

For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies Read More

SECOND OPINION: Don’t Be Fooled.  Drug Companies Are Responsible For High Drug Prices

Oct 23, 2018

Repeating the same false claim over and over again doesn’t make it true.  Read More

CSRxP Statement On PhRMA’s DTC Advertising Announcement

Oct 15, 2018

The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement Read More

CSRxP Statement On HHS DTC Advertising Announcement

Oct 15, 2018

CSRxP issued the following statement in response to the U.S. Department of Read More

ICYMI: CSRxP Calls On FDA To Break Down Barriers To Affordable Drugs

Oct 2, 2018

Through the advancement of modern medicine, biologic drugs are providing new Read More

Congress Rejects Big Pharma Bailout

Sep 26, 2018

Defeat For Price-Gouging Drug Manufacturers; Victory For Taxpayers & Read More

CSRxP Urges Congress to Stop Big Pharma’s $4 Billion Bailout

Sep 25, 2018

Washington, D.C. – Today the Campaign for Sustainable Rx Pricing Read More